Long-Term Outcomes of Faricimab in Diabetic Macular Edema
Four-year data show faricimab delivers sustained vision and retinal improvements in diabetic macular edema, reducing injection frequency and easing treatment burden for patients with diabetes.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.